Abstract:Objective To observe the expression between ETS-1 and neuronal cadherin (E-cadherin, N-cadherin) and Vimentin in non-small cell lung cancer (NSCLC) tissues and to study the clinical correlation of those molecules. Method 110 cases of NSCLC patients who had undergone surgical resection were confirmed pathologically and were included in this study, of which the tumor tissues and normal lung tissues that were at least 3 cm away from the tumor were selected. The immunohistochemistry SP method was used to detect the expression of ETS-1, E-cadherin, N-cadherin and Vimentin, then the correlation was investigated. Result In NSCLC tissues, the positive expression rate of ETS-1, N-cadherin and Vimentin [65%(72/110), 56%(62/110), and 34%(37/110), respectively] were significant-ly higher than those in normal lung tissues [6%(3/50), 8%(4/50), 2%(1/50), respectively] (all P<0.01); The positive expression rate of E-cadherin was 41%(45/110), which was significantly lower than the 84%(42/50) of normal lung tissues. The expression of ETS-1 was positively correlated with the lymph node metastasis and TNM staging (P<0.05), but was not associated with gender, age, tumor diameter, histological type and differentiation degree (P>0.05). The expression of E-cadherin was negatively correlated with tumor differentiation degree, the lymph node metastasis and TNM staging (P<0.05). The expression of N-cadherin and Vimentin were positively correlated with tumor differ-entiation degree, the lymph node metastasis and TNM staging (P<0.05). The expression of E-cadherin, N-cadherin and Vimentin were not correlated with gender, age, tumor diameter and histological type (P>0.05). While the expres-sion of ETS-1 was negatively correlated with E-cadherin but positively correlated with N-cadherin in NSCLC. Con-clusion The expression of ETS-1, E-cadherin, N-cadherin and Vimentin are closely related with metastasis of NSCLC, thus the detection on the expression of those molecules will be effective in estimating the metastasis and prognosis of NSCLC.

Distinctive E‐cadherin and Epidermal Growth Factor Receptor Expression in Metastatic and Nonmetastatic Head and Neck Squamous Cell Carcinoma

Egfr and Her2 Expression in Primary Cervical Cancers and Corresponding Lymph Node Metastases: Implications for Targeted Radiotherapy

Comparison of the Epidermal Growth Factor Receptor Protein Expression Between Primary Non-Small Cell Lung Cancer and Paired Lymph Node Metastases: Implications for Targeted Nuclide Radiotherapy.

High Expression of E-cadherin in Pleural Effusion Cells Predicts Better Prognosis in Lung Adenocarcinoma Patients.

Egfr, Her2 and Her3 Expression in Esophageal Primary Tumours and Corresponding Metastases

EGFR, HER2, and HER3 Expression in Laryngeal Primary Tumors and Corresponding Metastases

P3-015: Clinicopathologic Features and Epidermal Growth Factor Receptor Mutations Associated with Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer

Expression of E-cadherin in Cervical Lymph Nodes from Primary Oral Squamous Cell Carcinoma Patients.

Expressions of E-cadherin in non-small cell lung cancer and it correlation with prognosis]

Clinical signi W cance of EphA 2 expression in squamous-cell carcinoma of the head and neck

Immunohistochemical Analysis Of Phosphotyrosine Signal Transducer And Activator Of Transcription 3 And Epidermal Growth Factor Receptor Autocrine Signaling Pathways In Head And Neck Cancers And Metastatic Lymph Nodes

C-Met As a Molecular Marker for Esophageal Squamous Cell Carcinoma and Its Association with Clinical Outcome

E-cadherin Expression and Prognosis of Head and Neck Squamous Cell Carcinoma: Evidence from 19 Published Investigations.

Reduced E-cadherin expression is associated with lymph node metastases in laryngeal squamous cell carcinoma

Clinicopathological Significance of E-Cadherin and PCNA Expression in Human Non-Small Cell Lung Cancer

Biomarker Quantification by Multiplexed Quantum Dot Technology for Predicting Lymph Node Metastasis and Prognosis in Head and Neck Cancer

Is E-cadherin immunoexpression a prognostic factor for head and neck squamous cell carcinoma (HNSCC)? A systematic review and meta-analysis

Prognostic Impact and Potential Interaction of EGFR and C-Met in the Progression of Esophageal Squamous Cell Carcinoma

High Epidermal Growth Factor Receptor Expression in Metastatic Lymph Nodes May Be More Prognostic Than in Primary Tumor for Colorectal Cancer Survival

The Clinical Significance of the Expression of E - Cd and EGFR Proteins in Supraglottic Carcinoma

The correlation between expression of ETS-1 and E-cadherin, N-cadherin and Vimentin in non-small cell lung cancer